Clinical Trial: Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: A Phase III, Randomized, Controlled, Open-Label, Multicenter, Parallel Group Study Using Provisions for Exception From Informed Consent Requirements Designed to Evaluate the Safety and Efficacy of Pol

Brief Summary: This study is designed to assess the survival benefit of administering PolyHeme to severely injured trauma patients in hemorrhagic shock beginning in the prehospital setting, where blood is not available, and continuing throughout a 12-hour postinjury hospital setting.

Detailed Summary:
Sponsor: Northfield Laboratories

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Northfield Laboratories

Dates:
Date Received: January 28, 2004
Date Started:
Date Completion:
Last Updated: July 31, 2006
Last Verified: July 2006